What caused Arvee Laboratories' recent price increase?

A significant spike in trading volume likely drove the recent 15.6% increase in Arvee Laboratories' stock price on the NSE. This could be attributed to heightened investor interest or company-specific news.

How does Arvee Laboratories' valuation compare to its earnings?

With a PE ratio of 634.22 and an EPS of ₹0.36, Arvee Laboratories is highly valued compared to its earnings, suggesting high investor expectations for future growth.

What sector does Arvee Laboratories operate in?

Arvee Laboratories operates in the specialty chemicals sector in India, producing various chemical intermediates and polymer modifiers primarily for export.

What is Meyka AI's outlook on Arvee Laboratories?

Meyka AI gives Arvee Laboratories a 'Hold' rating, reflecting its current score of 59.4, indicating a cautious outlook in light of its high valuation and sector positioning.

What are the forecasted price targets for Arvee Laboratories?

The price targets for Arvee Laboratories are forecasted at ₹207.87 in one year, potentially rising to ₹329.24 over seven years, according to market analysis trends.

IN Stocks

Arvee Laboratories: Unpacking the Recent Volume Spike and Price Surge on NSE

ByHuzaifa Zahoor December 9, 2025December 9, 2025

Arvee Laboratories (India) Ltd. (ARVEE.NS) recently caught investors’ attention with a 15.6% jump in its stock price to ₹228.32. This came on the back of a significant volume spike, making it a hot topic on the NSE.